In conclusion, the rs1126616 SNP of the SPP1 gene is independently associated with cardiovascular events in a cohort of CKD patients regardless of OPN levels and thus, if validated, could be used to predict CVE risk in CKD patients. This evidence concerns the gene SPP1 and chronic kidney disease.